High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 910-917

  Cockerill, Gillian W ^a,c   Saklatvala, Jeremy ^d   Ridley, Simon H ^d   Yarwood, Helen ^a   Miller, Norman E ^e   Oral, Barbaros ^a   Nithyanathan, Saro ^c   Taylor, Graham ^b   Haskard, Dorian O ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Coronary artery disease; Granulocyte macrophage colony stimulating factor; Inflammation; Prostacyclin

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROSTAGLANDIN SYNTHASE; SYNAPSIN I; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING SITE; CORONARY ARTERY DISEASE; DNA BINDING; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0032921956     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.910     Document Type: Article

References (74)

1. World Health Organization. World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1993.
2. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975;1:16-20.
3. Yaari S, Goldbourt U, Even-Zohar S, Neufeld HN. HDL and total cholesterol: association with total, cardiovascular and cancer mortality in a seven year prospective study of 10,000 men. Lancet. 1981;1:1011-1015.
4. Gordon DJ, Probsfield JL, Garrison RJ, Neatoin JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
5. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Cliff SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265-267.
6. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1994;91:9607-9611.
7. Paszty C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest. 1993;94:899-903.
8. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high-density lipoprotein plasma fraction in cholesterol fed rabbits. J Clin Invest. 1990;85:1234-1241.
9. Glomset JA. The plasma lecithin:cholesterol acetyltransferase reaction. J Lipid Res. 1968;9:155-167.
10. Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC. Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta. 1991;1085:273-298.
11. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 1996;97:2917-2923.
12. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275-283.
13. Cockerill GW, Reed SC. High-density lipoprotein - multipotent effects on cells of the vasculature. Int Rev Cytol Surv Cell Biol. 1998;188:In press.
14. Mackness MI, Abbot C, Arrol S, Durrington PN. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J. 1993;294:829-834.
15. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM. Monocyte transmigration induced by modification of low density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88:2039-2046.
16. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidised low density lipoprotein. J Clin Invest. 1995;96:2882-2891.
17. Tauber J-P, Cheng J, Gospodarowicz D. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J Clin Invest. 1980;66:696-708.
18. Levine DM, Parker TS, Donnely TM, Walsh A, Rubin AL. In vivo protection against endotoxin by high density lipoprotein. Proc Natl Acad Sci U S A. 1993;90:12040-12044.
19. Pajkrt D, Doran JE, Koster F, Lerch PG, Arnet B, Van der Toll T, ten Cate JW, van Deventer SJH. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med. 1996; 184:1601-1608.
20. Cotran RS, Pober JS. Endothelial activation: its role in inflammation and immune reaction. In: Simionescu N, Simionescu MS, eds. Endothelial Cell Biology. New York, NY. Plenum Press; 1988:335-347.
21. Springer TA. Traffic signals for lymphocyte recruitment and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
22. Collins T, Read MA, Neish AS, Whitely M, Thanos M, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-KB and cytokine-inducible enhancers. FASEB J. 1995;9:899-909.
23. Read MA, Whiteley MZ, Williams AJ, Collins T. NF-KB, and IKBα. An inducible regulatory system in endothelial activation. J Exp Med. 1994; 179:503-512.
24. De Martin R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H, Bach FH. Cytokine-inducible expression in endothelial cells of an IKBα-like gene is regulated by NF-KB. EMBO J. 1993;12:2773-2779.
25. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteosome pathway is regulated for cytokine-induced and leukocyte adhesion molecules expression. Immunity. 1995;2:493-506.
26. Gerrity RG, Naito HK, Richardson M, Schwartz CJ. Dietary induced atherogenesis in swine: morphology of the intima in pre-lesion stages. Am J Pathol. 1979;95:775-792.
27. Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 1988;60:459-464.
28. Poston RN, Haskard DO, Goucher JR, Gall NP, Johnson-Tiddey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665-673.
29. Van de Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141:161-168.
30. Wood KM, Cadogan MD, Ranshaw AL, Parums DV. The distribution of adhesion molecules in human atherosclerosis. Histopathology. 1993;22: 437-444.
31. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Furgerson M, Hudkins K, Benjamin CD, Lobb R, Alpers CE. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest. 1993;92:945-951.
32. Johnson-Tiddey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlaying atherosclerotic plaques: coexpression with intercellular adhesion molecule-1. Am J Pathol. 1994;144:952-961.
33. Wall RT, Harker LA, Quadracci LJ, Striker GE. Factors influencing endothelial cell proliferation in vitro. J Cell Physiol. 1978;96:203-213.
34. Cockerill GW, Rye K-A, Gamble JR, Vadas MA, Barter PJ. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:1987-1994.
35. Mackness MI. Why plasma should not be used to study paraoxonase. Atherosclerosis. 1998;136:195-196.
36. Cohen J, McConnell JS. Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J Infect Dis. 1984;150:916-924.
37. Lerch PG, Forlsch V, Hadever G, Bolli R. Production and characterisation of a reconstitituted high density lipoprotein for therapeutic application. Vox Sang. 1996;71:155-164.
38. Wellicome SM, Thornhill MH, Pitzalis C, Thomas DS, Lanchbury JS, Panayi GS, Haskard DO. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1 or lipopolysaccharide. J Immunol. 1990;144:2558-2565.
39. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
40. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984;81:1991-1995.
41. Cockerill GW, Bert AG, Ryan GR, Gamble JR, Vadas MA, Cockerill PN. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and T-cell transcription factor NFAT. Blood 1995;86:2689-2698.
42. Dignani JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1984;11:1475-1489.
43. Schindler U, Baichwal VR. Three NF-KB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 1994;14:5820-5829.
44. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, Shannon MF. Requirement for NF-KB p65, and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood. 1994;9:1-11.
45. Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-KB with other transcription factors families. Oncogene. 1993;8: 3189-3197.
46. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
47. Nathwani AC, Gale KM, Pemberton KD, Crossman DC, Tuddenham EG, McVey JH. Functional analysis of the human TF gene promoter. Br J Haematol. 1994;88:122-128.
48. Calebresi L, Franceschini G, Sirtori CR, Plama A, De Sarsella M, Ferrante P, Taramelli D. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem Biophys Res Commun. 1996;238:61-65.
49. Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible. cyclosporin A sensitive enhancer. Proc Natl Acad Sci U S A. 1993;90:2466-2470.
50. Jain, J, McCaffrey PG, Miner Z, Kerpola TK, Lambert JN, Verdine GL, Curran T, Rao A. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 1992;365:352-355.
51. Mollers C, Drobnik W, Resink T, Schmitz G. HDL and LDL mediated signal transduction in cultured human fibroblasts. Cell Signal. 1995;7: 695-707.
52. Su Z, Luo ZH, Niu XL, Guo ZG. High density lipoproteins increase cytoplasmic free calcium in bovine aortic endothelial cells. J Lipid Med Cell Signal. 1996;15:5-15.
53. 2 synthase activity. Biochim Biophys Acta. 1980;620:352-355.
54. 2 synthase activity. Prostaglandins Med. 1981;6:515-518.
55. Fleisher LN, Tall AR, Witt LD, Miller RW, Cannon PJ. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoprotein. J Biol Chem. 1982;257:6653-6655.
56. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992;89:7384-7388.
57. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 1991;88:2692-2696.
58. De Witt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression Biochem Biophys Acta. 1991;1083:121-134.
59. Whelan, J, Ghersa P, Van Huijsduijnen R, Gray J, Chandra G, Talabot F, DeLamater JF. An NFkB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acid Res. 1991;19:2645-2653.
60. Shreck R, Baeuerle PA. NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol Cell Biol. 1990;10:1281-1289.
61. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor KB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes Arthritis Rheum. 1997;40:226-236.
62. Wolle J, Hill RR, Ferguson E, Devall LJ, Trivedi BK, Newton RS, Saxena U. Selective inhibition of tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression by a novel flavonoid. Arterioscler Thromb Vasc Biol. 1996;16:1501-1508.
63. Grilli M, Chiu J-S, Lenardo M. NF-kB. and Rel. Participants in a multiform transcriptional regulatory system. Int Rev Cytol Surv Cell Biol. 1993;143:1-62.
64. Farber HW, Antonov AS, Romanov YA, Smirnov VN, Scarfo LM, Beer DJ. Cytokine secretion by human aortic endothelial cells is related to degree of atherosclerosis. Am J Physiol. 1992;262:H1088-H1095.
65. Stuhlmeier KM, Tarn C, Csizmadia V, Bach FH. Selective suppression of endothelial cell activation by arachidonic acid. Eur J Immunol. 1996;26: 1417-1423.
66. Vinals M, Matinez-Gonzalez J, Badimon JJ, Badimon L. HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arteriocier Thromb Vasc Biol. 1997;17:3481-3488.
67. Ristmaki A, Garfinkel S, Wessendor J, Maciag T, Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha: evidence for posttranscriptional regulation. J Biol Chem. 1994;269:11769-11775.
68. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J Biol Chem. 1995;270:24965-24971.
69. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor KB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 95;270:31315-31373.
70. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor kB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 1997;40:226-236.
71. Newton R, Lieske ME, Bergmann M, Adcock IM, Barnes PJ. Evidence for involvement of NF-KB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun. 1997;237:28-32.
72. Hu R-M, Chuang M-Y, Prins B, Kashyap ML, Frank HJL, Pedram A, Levin ER. High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells. J Clin Invest. 1994;93:1056-1062.
73. Pomerantz KB, Summers B, Hajjar DP. Eicosonoid metabolism in cholesterol-enriched arterial smooth muscle cells. Evidence for reduced posttranscriptional processing of cyclooxygenase I and reduced cyclooxygenase II gene expression. Biochemistry. 1984;32:13624-13635.
74. Pomerantz KB, Hajjar DP. High-density lipoprotein-induced cholesterol efflux from arterial smooth muscle cells derived foam cells: functional relationship of this cholesteryl ester cycle and eicosonoid biosynthesis. Biochemistry. 1990;29:1892-1899.